financetom
Business
financetom
/
Business
/
BRIEF-Impact Biomedical Inc Says It Adds Dawson James Securities Inc As An Underwriter To IPO - SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
BRIEF-Impact Biomedical Inc Says It Adds Dawson James Securities Inc As An Underwriter To IPO - SEC Filing
Aug 20, 2024 3:02 PM

Aug 20 (Reuters) - Impact Biomedical Inc:

* IMPACT BIOMEDICAL INC SAYS IT ADDS DAWSON JAMES SECURITIES

INC

AS AN UNDERWRITER TO IPO - SEC FILING

Source text for Eikon:

Further company coverage:

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Indian Hotels sees uptick in leisure travel; surge in advance bookings for Diwali, Christmas
Indian Hotels sees uptick in leisure travel; surge in advance bookings for Diwali, Christmas
Oct 18, 2021
Puneet Chhatwal, MD & CEO of Indian Hotels Company, on Monday, said that most leisure destinations are seeing revenue above the pre-COVID levels. He further said that the company is seeing a surge in advance bookings for Diwali and Christmas. Chhatwal believes Indian Hotels will go back to pre-COVID levels by Q4.
The Disruption Economy - L.I.M.E 13 Theme explained by Industry stalwarts
The Disruption Economy - L.I.M.E 13 Theme explained by Industry stalwarts
Oct 18, 2021
Mumbai: This is the 13th year of L.I.M.E (Lessons in Marketing Excellence), one of the most coveted B-School challenges of...
WazirX launches Crypto Transparency Report to build trust among stakeholders
WazirX launches Crypto Transparency Report to build trust among stakeholders
Oct 18, 2021
Initiatives like the Transparency report by WazirX can help set the bedrock for a comprehensive understanding of why India needs to support such initiatives.
HCL Tech confident of achieving FY22 margin guidance and maintaining double-digit growth
HCL Tech confident of achieving FY22 margin guidance and maintaining double-digit growth
Oct 18, 2021
HCL Technologies Ltd reported a 4 percent year-on-year (YoY) jump in consolidated net profit at Rs 3,259 crore for the second quarter ended September 30, 2021. However slippages in products and platforms (P&P) business hit margins. In an interview with CNBC-TV18, C Vijayakumar, Chief Executive Officer, and Prateek Aggarwal, Chief Financial Officer at HCL Technologies, shared the company's business outlook. The management remains confident of achieving its guidance of 19-21 percent for the full year. The IT company also expects to maintain its growth in double-digits.
Copyright 2023-2026 - www.financetom.com All Rights Reserved